| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Case report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice
Avtorji:ID Štuhec, Matej (Avtor)
Datoteke:.pdf RAZ_Stuhec_Matej_2025.pdf (422,74 KB)
MD5: 1269747135910B663F40D7B5B7287FB1
 
URL https://doi.org/10.3389/fpsyt.2025.1677152
 
URL https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1677152/full
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.03 - Drugi znanstveni članki
Organizacija:MF - Medicinska fakulteta
Opis:Introduction: Pharmacotherapy of depression represents a significant challenge in the management of depression in primary care. Although effective treatments have been available, many patients are still not adequately managed. Clinical pharmacists represent one of the possible strategies in the management, although this practice is rarely seen outside the United Kingdom and the United States. Aim: The aim of the case was to evaluate the impact of clinical pharmacist prescribers on depression treatment. Methods: A longitudinal, observational, case-based medication review by a pharmacist prescriber was conducted for a 63-year-old Slovenian patient in a primary care ambulatory setting. The review included three structured medication review assessments performed by a clinical pharmacist prescriber at defined intervals: first observation, two months post-intervention, and six months after first observation. The pharmacists conducted medication reviews and prescribed medications like physicians, operating within a collaborative practice agreement as dependent prescribers. Predefined outcomes included diabetes management (HbA1c and blood glucose), lipid levels (S-LDL), pain (Visual Analogue Scale [VAS]), depression (Patient Health Questionnaire-9 [PHQ-9]), and quality of life (assessed via EQ-5D-VAS). The patient’s complete medication regimens were reviewed, focusing on dosage appropriateness, indication matching, potential drug-drug interactions, and medication adherence. Results: A 63-year-old male Slovenian patient diagnosed with depression, type 2 diabetes with polyneuropathy, and hypothyroidism underwent two medication reviews between December 2024 and July 2025. The pharmacist prescribed amitriptyline and semaglutide (accepted by the patient’s physician). Notable improvements were observed in glycemic control (HbA1c reduced from 9.9% to 8.2%), and quality of life (EQ-5D-VAS score improved from 30/100 to 80/100). Depression symptoms also resolved, with the PHQ-9 score improving from 11 to 4. Conclusions: This case study demonstrates that interventions by a clinical pharmacist prescriber during the medication review process resulted in improved clinical outcomes in the treatment of depression, as well as enhanced quality of life. It represents an important contribution to the development of pharmacist prescribing roles in depression management within primary care settings outside of the United Kingdom and the United States.
Ključne besede:depression, pharmacist prescriber, clinical pharmacy, ambulatory care, medication review
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:11.08.2025
Datum sprejetja članka:31.07.2025
Datum objave:28.08.2025
Založnik:Frontiers
Leto izida:2025
Št. strani:Str. 1-7
Številčenje:Letn. 16, št. članka 1677152
PID:20.500.12556/DKUM-95306 Novo okno
UDK:616.89:615
COBISS.SI-ID:248512771 Novo okno
DOI:/10.3389/fpsyt.2025.1677152 Novo okno
ISSN pri članku:1664-0640
Datum objave v DKUM:15.09.2025
Število ogledov:132
Število prenosov:12
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Frontiers in psychiatry
Skrajšan naslov:Front. psychiatry
Založnik:Frontiers Research Foundation
ISSN:1664-0640
COBISS.SI-ID:54153314 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:V3-24041-2024
Naslov:Preučitev koristi in tveganj pri odvisnem predpisovanju zdravil v okviru farmacevtske obravnave bolnika

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici